Economic implications of 21-gene recurrence score assay: US multicenter experience.
Publication
, Journal Article
Hornberger, J; Lyman, GH; Chien, R
Published in: J Clin Oncol
August 1, 2010
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
August 1, 2010
Volume
28
Issue
22
Start / End Page
e382
Location
United States
Related Subject Headings
- United States
- Recurrence
- Oncology & Carcinogenesis
- Humans
- Gene Expression Profiling
- Female
- Costs and Cost Analysis
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hornberger, J., Lyman, G. H., & Chien, R. (2010). Economic implications of 21-gene recurrence score assay: US multicenter experience. J Clin Oncol, 28(22), e382. https://doi.org/10.1200/JCO.2010.28.8944
Hornberger, John, Gary H. Lyman, and Rebecca Chien. “Economic implications of 21-gene recurrence score assay: US multicenter experience.” J Clin Oncol 28, no. 22 (August 1, 2010): e382. https://doi.org/10.1200/JCO.2010.28.8944.
Hornberger J, Lyman GH, Chien R. Economic implications of 21-gene recurrence score assay: US multicenter experience. J Clin Oncol. 2010 Aug 1;28(22):e382.
Hornberger, John, et al. “Economic implications of 21-gene recurrence score assay: US multicenter experience.” J Clin Oncol, vol. 28, no. 22, Aug. 2010, p. e382. Pubmed, doi:10.1200/JCO.2010.28.8944.
Hornberger J, Lyman GH, Chien R. Economic implications of 21-gene recurrence score assay: US multicenter experience. J Clin Oncol. 2010 Aug 1;28(22):e382.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
August 1, 2010
Volume
28
Issue
22
Start / End Page
e382
Location
United States
Related Subject Headings
- United States
- Recurrence
- Oncology & Carcinogenesis
- Humans
- Gene Expression Profiling
- Female
- Costs and Cost Analysis
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis